During a panel discussion at the MedCity INVEST Digital Health conference, investors shared what they’re looking for from AI startups and what their red flags

Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH. Beyond the $2.4 billion

We’re in the middle of a fundamental shift that’s giving consumers more power and choice over their health coverage while creating healthy competition in the

[Sponsored] An upcoming webinar sponsored by Solera Health will explore how employers can develop benefit strategies that improve employee outcomes and fit their budgets. The

Malingering, deliberately feigning or exaggerating symptoms appears to be rising. This shift brings with it a tangled web of clinical, operational, and ethical challenges that

Take part in our Reader Survey and help us continue to grow! The post Do You Value MedCity News? Take Our Survey! appeared first on